Is Eli Lilly using ‘granfluencers’ to raise awareness of its Alzheimer’s med?
By
Marc Iskowitz
Sep 04, 2024
Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer’s drug marketing scene.
Multiple sclerosis linked to lower risk for Alzheimer’s disease pathology
By
Haymarket Media
Aug 30, 2024
A lower rate of amyloid-β plasma biomarker positivity was seen in multiple sclerosis patients compared with non-MS controls.
Studies highlight increasing dementia deaths, contributing factors to diagnosis and cognitive decline
By
Kimberly Bonvissuto
Aug 16, 2024
More people are dying from dementia, and location and demographics are among the factors that may contribute to not only a dementia diagnosis, but also to how quickly someone will experience cognitive...
CCRC program bridges gap between assisted living, memory care for residents
By
Kimberly Bonvissuto
Aug 14, 2024
A full memory support program with a growing waiting list prompted one continuing care retirement / life plan community to create a program that bridges the gap between assisted living and full memory...
Alzheimer’s prognosis models should expand data sources
By
Kristen Fischer
Aug 12, 2024
Integrating data from nursing home electronic health records (EHRs) and claims in addition to the minimum data set (MDS) — data required for nursing home residents — could be better than just relying...